Long-term survival outcomes of systemic therapy in patients with isolated and mixed medullary thyroid cancer.

Fawzy, Manal S; Alenezi, Aziza Ali; Abu AlSel, Baraah T; Toraih, Eman A

Fawzy, Manal S; Alenezi, Aziza Ali; Abu AlSel, Baraah T; Toraih, Eman A.

Afiliación

Fawzy MS; Department of Biochemistry, Faculty of Medicine, Northern Border University, Arar, Saudi Arabia.
Alenezi AA; Unit of Medical Research and Postgraduate Studies, Faculty of Medicine, Northern Border University, Arar, Saudi Arabia.
Abu AlSel BT; University Health Center, Northern Border University, Arar, Saudi Arabia.
Toraih EA; Department of Pathology, Faculty of Medicine, Northern Border University, Arar, Saudi Arabia.

Heliyon ; 10(13): e33654, 2024 Jul 15.

Article en En | MEDLINE | ID: mdl-39040258

Palabras clave

Cancer-specific survival; Medullary thyroid carcinoma; SEER; Systemic therapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Heliyon Año: 2024 Tipo del documento: Article País de afiliación: Arabia Saudita Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google